US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
US6749868B1
(en)
*
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US6537579B1
(en)
*
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
US20070117863A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US5498421A
(en)
*
|
1993-02-22 |
1996-03-12 |
Vivorx Pharmaceuticals, Inc. |
Composition useful for in vivo delivery of biologics and methods employing same
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
US6143211A
(en)
*
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
CN101579335B
(zh)
*
|
1997-06-27 |
2016-08-03 |
阿布拉科斯生物科学有限公司 |
药剂的制剂及其制备和应用方法
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
EP1023050B1
(en)
*
|
1997-06-27 |
2013-09-25 |
Abraxis BioScience, LLC |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
ES2355186T3
(es)
*
|
1997-09-05 |
2011-03-23 |
Maruho K.K. |
Preparaciones de nanocápsulas para tratar enfermedades intraarticulares.
|
HUP9701554D0
(en)
*
|
1997-09-18 |
1997-11-28 |
Human Oltoanyagtermeloe Gyogys |
Pharmaceutical composition containing plazma proteins
|
US6884842B2
(en)
|
1997-10-14 |
2005-04-26 |
Alnis Biosciences, Inc. |
Molecular compounds having complementary surfaces to targets
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
AU5241199A
(en)
*
|
1998-07-30 |
2000-02-21 |
Novopharm Biotech Inc. |
Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
|
GB9820746D0
(en)
†
|
1998-09-23 |
1998-11-18 |
Pharmax Limited |
Micronised pharmaceutical compositions
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
AT406054B
(de)
*
|
1998-11-04 |
2000-02-25 |
Andreas Bernkop-Schnuerch |
Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
DE19856432A1
(de)
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
DE19919769A1
(de)
|
1999-04-30 |
2000-11-02 |
Henkel Kgaa |
Verwendung nanoskaliger antimikrobieller Wirkstoffe in Körperdeodorantien
|
GB9910975D0
(en)
*
|
1999-05-13 |
1999-07-14 |
Univ Strathclyde |
Rapid dehydration of proteins
|
CA2684454A1
(en)
*
|
1999-05-21 |
2000-11-18 |
American Bioscience, Llc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US7919119B2
(en)
*
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
GB2350297A
(en)
*
|
1999-05-27 |
2000-11-29 |
Abbott Lab |
Injectable halogenated anesthetic formulation in emulsion form
|
US6610317B2
(en)
*
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
DE19932157A1
(de)
*
|
1999-07-13 |
2001-01-18 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
JP2003511420A
(ja)
*
|
1999-10-13 |
2003-03-25 |
カイロン コーポレイション |
タンパク質から細胞性免疫応答を得る方法
|
US20020041898A1
(en)
*
|
2000-01-05 |
2002-04-11 |
Unger Evan C. |
Novel targeted delivery systems for bioactive agents
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
JP2003520210A
(ja)
*
|
2000-01-05 |
2003-07-02 |
イマレックス セラピューティクス, インコーポレイテッド |
低い水溶性を有する薬物の送達のための薬学的処方物
|
GB2359747B
(en)
*
|
2000-02-29 |
2002-04-24 |
Maelor Pharmaceuticals Ltd |
Anaesthetic formulations
|
CA2403704C
(en)
*
|
2000-03-23 |
2012-04-10 |
Collaborative Technologies, Inc. |
Method for preparing high pressure/high shear dispersions containing physiologically active ingredients
|
ITMI20001107A1
(it)
*
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
US6623765B1
(en)
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
CA2423484A1
(en)
|
2000-09-27 |
2002-04-04 |
Verion Inc. |
Instant water dissolvable encapsulate and process
|
EP1324885A1
(en)
*
|
2000-10-02 |
2003-07-09 |
Kimberly-Clark Worldwide, Inc. |
Recording medium with nanoparticles and methods of making the same
|
US7803149B2
(en)
*
|
2002-07-12 |
2010-09-28 |
Cook Incorporated |
Coated medical device
|
SK7092003A3
(en)
|
2000-11-09 |
2004-06-08 |
Neopharm Inc |
SN-38 lipid complexes and methods of use
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US6869617B2
(en)
*
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US7115565B2
(en)
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
US20040022861A1
(en)
*
|
2001-01-30 |
2004-02-05 |
Williams Robert O. |
Process for production of nanoparticles and microparticles by spray freezing into liquid
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
CA2440935A1
(en)
*
|
2001-03-13 |
2002-09-19 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
DE10115740A1
(de)
|
2001-03-26 |
2002-10-02 |
Ulrich Speck |
Zubereitung für die Restenoseprophylaxe
|
US20040146564A1
(en)
*
|
2001-04-05 |
2004-07-29 |
Muriel Subirade |
Process for making delivery matrix and uses thereof
|
EP1800670A1
(en)
*
|
2001-04-20 |
2007-06-27 |
The University of British Columbia |
Micellar drug delivery systems for hydrophobic drugs
|
SG126676A1
(en)
*
|
2001-05-09 |
2007-01-30 |
Nanomaterials Tech Pte Ltd |
Process for the controlled production of organic particles
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
EP1408876A4
(en)
|
2001-06-22 |
2004-09-22 |
Durect Corp |
ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
|
GB0116074D0
(en)
*
|
2001-06-29 |
2001-08-22 |
Univ Strathclyde |
Nanoparticle structures
|
US20040013698A1
(en)
*
|
2001-07-09 |
2004-01-22 |
Aust Duncan T |
Method for preparing topical preparations containing skin protective agents with enhanced barrier properties
|
TWI252847B
(en)
*
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
TWI297335B
(en)
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
TWI332943B
(en)
*
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
US20040018250A1
(en)
*
|
2001-07-11 |
2004-01-29 |
Ceccoli Joseph D. |
Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solids and oils
|
CA2456806C
(en)
*
|
2001-08-08 |
2011-10-18 |
Brown University Research Foundation |
Methods for micronization of hydrophobic drugs
|
US20030199587A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique Cmax properties
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
BR0212833A
(pt)
*
|
2001-09-26 |
2004-10-13 |
Baxter Int |
Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
|
JPWO2003034302A1
(ja)
*
|
2001-10-15 |
2005-02-03 |
株式会社シュタルク |
コンテンツ配信用サーバ及びこれを備えたコンテンツ配信システム
|
CA2461556A1
(en)
*
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Compositions and methods for delivery of microparticles of poorly water soluble drugs and methods of treatment
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
WO2003033526A2
(en)
|
2001-10-19 |
2003-04-24 |
Isotechnika Inc. |
Synthesis of cyclosporin analogs
|
WO2003037359A1
(fr)
*
|
2001-10-29 |
2003-05-08 |
Chengdu Somo Namotechnology Co., Ltd. |
Nanoparticule de composants de medicaments insolubles et procede de production correspondant
|
AU2003210517A1
(en)
*
|
2002-02-04 |
2003-09-02 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
CA2479665C
(en)
*
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
WO2003082213A2
(en)
*
|
2002-03-28 |
2003-10-09 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US20040082521A1
(en)
*
|
2002-03-29 |
2004-04-29 |
Azaya Therapeutics Inc. |
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
ITMI20020680A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
ITMI20020681A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
AU2003263024A1
(en)
*
|
2002-04-23 |
2003-11-10 |
Christopher Mcconville |
Process of forming and modifying particles and compositions produced thereby
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
CN100500221C
(zh)
*
|
2002-07-15 |
2009-06-17 |
爱尔康公司 |
用于眼科药物递送的生物可侵蚀膜剂
|
WO2004006959A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd |
Liquid dosage compositions of stable nanoparticulate active agents
|
GB0216700D0
(en)
*
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
DE10234165B4
(de)
*
|
2002-07-26 |
2008-01-03 |
Advanced Micro Devices, Inc., Sunnyvale |
Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material
|
ES2333318T3
(es)
|
2002-08-12 |
2010-02-19 |
Bend Research, Inc. |
Composiciones farmaceuticas de medicamentos con estructura semiordenada y de polimero.
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
WO2004035032A2
(en)
*
|
2002-08-20 |
2004-04-29 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
US7090868B2
(en)
*
|
2002-09-13 |
2006-08-15 |
University Of Florida |
Materials and methods for drug delivery and uptake
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
AU2002342808A1
(en)
*
|
2002-10-09 |
2004-05-04 |
Unibioscreen S.A. |
Extract with anti-tumor and anti-poisonous activity
|
AU2003287235A1
(en)
*
|
2002-10-28 |
2004-05-25 |
Polymerix Corporation |
Therapeutic compositions
|
CA2504268A1
(en)
*
|
2002-10-30 |
2004-11-18 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
US7179484B2
(en)
*
|
2002-11-06 |
2007-02-20 |
Azaya Therapeutics, Inc. |
Protein-stabilized liposomal formulations of pharmaceutical agents
|
WO2004045494A2
(en)
*
|
2002-11-20 |
2004-06-03 |
Bar-Ilan University |
Biological glue based on thrombin-conjugated nanoparticles
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
RU2361615C2
(ru)
*
|
2002-12-09 |
2009-07-20 |
Абраксис Байосайенс, Ллс. |
Композиции и способы доставки фармакологических агентов
|
KR20120068035A
(ko)
*
|
2002-12-09 |
2012-06-26 |
아브락시스 바이오사이언스, 엘엘씨 |
약리학적 물질의 조성물 및 그 전달방법
|
US6780896B2
(en)
*
|
2002-12-20 |
2004-08-24 |
Kimberly-Clark Worldwide, Inc. |
Stabilized photoinitiators and applications thereof
|
US7666410B2
(en)
|
2002-12-20 |
2010-02-23 |
Kimberly-Clark Worldwide, Inc. |
Delivery system for functional compounds
|
US8409618B2
(en)
|
2002-12-20 |
2013-04-02 |
Kimberly-Clark Worldwide, Inc. |
Odor-reducing quinone compounds
|
TWI330079B
(en)
*
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
EP1442753B1
(en)
*
|
2003-02-03 |
2007-02-21 |
Polaschegg, Hans-Dietrich, Dr.techn. |
Composition for the prevention of indwelling device related infection
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
US7968115B2
(en)
|
2004-03-05 |
2011-06-28 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of cancer
|
WO2004080396A2
(en)
*
|
2003-03-07 |
2004-09-23 |
The University Of Texas Md Anderson Cancer Center |
Liposomal curcumin for treatment of cancer
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
US20040247624A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US8476010B2
(en)
*
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
CA2539486A1
(en)
*
|
2003-10-02 |
2005-04-07 |
Sembiosys Genetics Inc. |
Methods for preparing oil bodies comprising active ingredients
|
US7438875B2
(en)
*
|
2003-10-16 |
2008-10-21 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using metal-modified silica particles
|
US7754197B2
(en)
|
2003-10-16 |
2010-07-13 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using coordinated polydentate compounds
|
US7837663B2
(en)
*
|
2003-10-16 |
2010-11-23 |
Kimberly-Clark Worldwide, Inc. |
Odor controlling article including a visual indicating device for monitoring odor absorption
|
US7678367B2
(en)
|
2003-10-16 |
2010-03-16 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using metal-modified particles
|
US7413550B2
(en)
|
2003-10-16 |
2008-08-19 |
Kimberly-Clark Worldwide, Inc. |
Visual indicating device for bad breath
|
US7488520B2
(en)
|
2003-10-16 |
2009-02-10 |
Kimberly-Clark Worldwide, Inc. |
High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
|
US7794737B2
(en)
|
2003-10-16 |
2010-09-14 |
Kimberly-Clark Worldwide, Inc. |
Odor absorbing extrudates
|
US7879350B2
(en)
*
|
2003-10-16 |
2011-02-01 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using colloidal nanoparticles
|
WO2005062985A2
(en)
*
|
2003-12-23 |
2005-07-14 |
American Bioscience, Inc. |
Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
|
CA2551117A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Abraxis Bioscience, Inc. |
Substituted melatonin derivatives, process for their preparation, and methods of use
|
US20070185217A1
(en)
*
|
2003-12-23 |
2007-08-09 |
Abraxis Bioscience, Inc. |
Propofol analogs, process for their preparation, and methods of use
|
US20050186230A1
(en)
*
|
2004-01-23 |
2005-08-25 |
Sd Pharmaceuticals, Inc. |
Elemene compositions containing liquid oil
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
EP1711163A2
(en)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Dispersions prepared by use of self-stabilizing agents
|
US8784881B2
(en)
|
2004-03-05 |
2014-07-22 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of diseases
|
US20080103213A1
(en)
*
|
2004-03-05 |
2008-05-01 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of neurofibromatosis
|
US20050226922A1
(en)
*
|
2004-04-13 |
2005-10-13 |
Mahmoud Ameri |
Apparatus and method for transdermal delivery of fentanyl-based agents
|
CA2469339A1
(en)
*
|
2004-06-07 |
2005-12-07 |
Bernard Charles Sherman |
Sustained release propafenone hydrochloride capsules
|
CN1993318B
(zh)
*
|
2004-06-23 |
2012-10-03 |
Synta医药公司 |
用于治疗癌症的双(硫代-酰肼酰胺)盐
|
JP4433918B2
(ja)
*
|
2004-07-15 |
2010-03-17 |
コニカミノルタエムジー株式会社 |
画像形成方法
|
KR100578382B1
(ko)
|
2004-07-16 |
2006-05-11 |
나재운 |
항암제의 전달체용 수용성 키토산 나노입자 및 그 제조방법
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
US20060198891A1
(en)
*
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
WO2006066063A1
(en)
*
|
2004-12-15 |
2006-06-22 |
Elan Pharma International Ltd. |
Nanoparticulate tacrolimus formulations
|
CA2598159A1
(en)
|
2005-02-18 |
2006-08-24 |
Abraxis Bioscience, Inc. |
Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
CN105288630A
(zh)
*
|
2005-02-18 |
2016-02-03 |
阿布拉科斯生物科学有限公司 |
治疗剂的组合和给予方式以及联合治疗
|
US8415388B2
(en)
|
2005-02-22 |
2013-04-09 |
Savvipharm Inc. |
Pharmaceutical compositions containing paclitaxel orotate
|
WO2006101972A2
(en)
*
|
2005-03-17 |
2006-09-28 |
Elan Pharma International Limited |
Injectable compositions of nanoparticulate immunosuppressive compounds
|
US7722581B2
(en)
*
|
2005-04-11 |
2010-05-25 |
Gholam A. Peyman |
Crystalline lens drug delivery
|
US20060229585A1
(en)
*
|
2005-04-11 |
2006-10-12 |
Minu, L.L.C. |
Drug delivery to the crystalline lens and other ocular structures
|
KR20080002939A
(ko)
|
2005-04-12 |
2008-01-04 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 퀴나졸린 유도체 제제
|
JP2008536875A
(ja)
*
|
2005-04-15 |
2008-09-11 |
シンタ ファーマシューティカルズ コーポレーション |
ビス(チオヒドラジド)アミド化合物による併用癌療法
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
BRPI0612071A2
(pt)
*
|
2005-06-14 |
2010-10-19 |
Baxter Int |
formulações farmacêuticas para minimizar interações entre fármacos
|
RU2451510C2
(ru)
|
2005-08-31 |
2012-05-27 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Композиции и способы получения слаборастворимых в воде лекарственных средств с увеличенной стабильностью
|
BRPI0615292A8
(pt)
|
2005-08-31 |
2018-03-06 |
Abraxis Bioscience Llc |
composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
|
GB2436745B8
(en)
*
|
2005-09-09 |
2019-03-13 |
Jae Woon Nah |
Method for enhancing the solubility of paclitaxel
|
US20070098802A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Isaac Farr |
Organic nanoparticles and associated methods
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
EP1954252B1
(en)
*
|
2005-12-02 |
2016-02-03 |
GlaxoSmithKline Biologicals SA |
Nanoparticles for use in immunogenic compositions
|
DE102005062440B4
(de)
*
|
2005-12-27 |
2011-02-24 |
Lts Lohmann Therapie-Systeme Ag |
Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen
|
WO2007074476A1
(en)
|
2005-12-28 |
2007-07-05 |
Dabur Pharma Limited |
A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions
|
SE529040C2
(sv)
|
2006-01-18 |
2007-04-17 |
Bows Pharmaceuticals Ag |
Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
JP4974533B2
(ja)
*
|
2006-01-30 |
2012-07-11 |
富士フイルム株式会社 |
ジスルフィド架橋したタンパク質ナノ粒子
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US7458953B2
(en)
*
|
2006-06-20 |
2008-12-02 |
Gholam A. Peyman |
Ocular drainage device
|
JP5571380B2
(ja)
*
|
2006-07-24 |
2014-08-13 |
ルミナス バイオサイエンシズ,インコーポレイテッド |
オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物
|
AU2007288338B2
(en)
|
2006-08-21 |
2012-05-03 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
US20080280987A1
(en)
*
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
EP2076254A2
(en)
*
|
2006-08-31 |
2009-07-08 |
Synta Pharmaceuticals Corporation |
Combination with bis(thiohydrazide amides) for treating cancer
|
CA2663003C
(en)
*
|
2006-09-08 |
2018-02-13 |
Justin Hanes |
Compositions and methods for enhancing transport through mucus
|
US9498528B2
(en)
*
|
2006-09-13 |
2016-11-22 |
Genzyme Corporation |
Treatment of multiple sclerosis (MS)
|
WO2008032327A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Organic nanoparticles obtained from microemulsions by solvent evaporation
|
AR063704A1
(es)
|
2006-09-14 |
2009-02-11 |
Makhteshim Chem Works Ltd |
Nanoparticulas de pesticida obtenida obtenidas a partir de microemulsiones y nanoemulsiones
|
WO2008036858A2
(en)
|
2006-09-20 |
2008-03-27 |
The Board Of Regents Of The University Of Texas System |
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
|
JP5099545B2
(ja)
*
|
2006-10-17 |
2012-12-19 |
公立大学法人大阪府立大学 |
化合物の溶解補助剤とそれを含む組成物
|
ES2367876T3
(es)
*
|
2006-11-15 |
2011-11-10 |
Abraxis Bioscience, Llc |
Derivados de análogos 18-amino sustituidos de la hidroquinona geldamicina con actividad citotóxica para el tratamiento de cáncer.
|
US7799954B2
(en)
*
|
2006-11-17 |
2010-09-21 |
Abraxis Bioscience, Llc |
Dicarbonyl derivatives and methods of use
|
PT2117520T
(pt)
|
2006-12-14 |
2018-12-04 |
Abraxis Bioscience Llc |
Terapia do cancro da mama com base no estado do receptor do hormona com nanoparticulas compreendendo taxane
|
JP5622393B2
(ja)
*
|
2006-12-15 |
2014-11-12 |
アブラクシスバイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
PT2481409T
(pt)
|
2007-03-07 |
2018-10-18 |
Abraxis Bioscience Llc |
Nanopartícula que compreende rapamicina e albumina como agente anticancerígeno
|
EP2146707A2
(en)
|
2007-05-03 |
2010-01-27 |
Abraxis BioScience, LLC |
Methods and compositions for treating pulmonary hypertension
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
CA2689914C
(en)
*
|
2007-06-01 |
2016-08-16 |
Abraxis Bioscience, Llc |
Use of protein-bound taxane nanoparticles in the treatment of recurrent gynecological cancers
|
CA2698812A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
AR063111A1
(es)
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
PL2244737T3
(pl)
|
2008-01-22 |
2020-05-18 |
The Board Of Regents Of The University Of Texas System |
Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu
|
WO2009126175A1
(en)
*
|
2008-04-10 |
2009-10-15 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
EP3159033B1
(en)
|
2008-05-01 |
2019-02-27 |
Bayer Intellectual Property GmbH |
Catheter balloon drug adherence techniques and methods
|
CN101658516B
(zh)
*
|
2008-08-26 |
2011-10-05 |
齐鲁制药有限公司 |
紫杉醇类药物组合物及其制备方法
|
EP2367425B1
(en)
|
2008-12-11 |
2018-02-28 |
Abraxis BioScience, LLC |
Combination therapy including a taxane and a further therapeutic agent
|
WO2010105172A1
(en)
|
2009-03-13 |
2010-09-16 |
Abraxis Bioscience, Llc |
Combination therapy with thiocolchicine derivatives
|
US7828996B1
(en)
*
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
BRPI1012525A2
(pt)
|
2009-04-15 |
2018-07-10 |
Abraxis Bioscience, Llc. |
composições de nanopatículas isentas de príons e métodos para sua fabricação
|
CN102573473B
(zh)
|
2009-06-09 |
2015-05-27 |
加利福尼亚资本权益有限责任公司 |
用作hedgehog 信号转导抑制剂的异喹啉、喹啉和喹唑啉衍生物
|
WO2010144394A1
(en)
|
2009-06-09 |
2010-12-16 |
Abraxis Bioscience, Llc |
Benzyl substituted triazine derivatives and their therapeutical applications
|
JP5785940B2
(ja)
|
2009-06-09 |
2015-09-30 |
アブラクシス バイオサイエンス, エルエルシー |
トリアジン誘導体類及びそれらの治療応用
|
CN101653611B
(zh)
*
|
2009-07-23 |
2012-05-09 |
复旦大学 |
一种白蛋白-阿霉素纳米制剂及其制备方法和应用
|
WO2011017835A1
(en)
*
|
2009-08-11 |
2011-02-17 |
Nanjing University |
Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding
|
RU2561055C2
(ru)
|
2009-08-25 |
2015-08-20 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Комбинированная терапия композициями наночастиц таксана и ингибиторами хэджхог
|
US10350364B2
(en)
|
2009-11-11 |
2019-07-16 |
Windgap Medical, Inc. |
Portable Drug Mixing and Delivery Device and Associated Methods
|
US9211283B2
(en)
|
2009-12-11 |
2015-12-15 |
Biolitec Pharma Marketing Ltd |
Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
|
WO2011097149A2
(en)
*
|
2010-02-03 |
2011-08-11 |
Oncbiomune, L.L.C. |
Taxane-and taxoid-protein compositions
|
CA3051495A1
(en)
|
2010-03-26 |
2011-09-29 |
Abraxis Bioscience, Llc |
Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma
|
KR20130028727A
(ko)
|
2010-03-29 |
2013-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
SG10201906075VA
(en)
|
2010-03-29 |
2019-08-27 |
Abraxis Bioscience Llc |
Methods of treating cancer
|
CA2795289A1
(en)
|
2010-04-08 |
2011-10-13 |
Sanford-Burnham Medical Research Institute |
Methods and compositions for enhanced delivery of compounds
|
EP2575803B1
(en)
|
2010-06-02 |
2017-07-26 |
Abraxis BioScience, LLC |
Methods of treating bladder cancer
|
SG186112A1
(en)
|
2010-06-04 |
2013-01-30 |
Abraxis Bioscience Llc |
Methods of treatment of pancreatic cancer
|
WO2011156119A1
(en)
|
2010-06-07 |
2011-12-15 |
Abraxis Bioscience, Llc |
Combination therapy methods for treating proliferative diseases
|
CN103202812B
(zh)
*
|
2010-08-09 |
2015-10-28 |
南京大学 |
一种制备用于体内递送药理活性物质的蛋白纳米粒的方法
|
CN103202813B
(zh)
*
|
2010-08-09 |
2015-09-30 |
南京大学 |
一种制备用于体内递送药理活性物质的蛋白纳米粒的方法
|
KR101223484B1
(ko)
*
|
2010-10-05 |
2013-01-17 |
한국과학기술연구원 |
사람 혈청 알부민-siRNA 나노입자 전달체
|
US8884027B2
(en)
|
2010-10-22 |
2014-11-11 |
University Of Rochester |
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
|
CA2767773C
(en)
|
2011-02-11 |
2015-11-24 |
Grain Processing Corporation |
Composition comprising a salt and a crystallization interrupter
|
WO2012118778A1
(en)
|
2011-02-28 |
2012-09-07 |
Sanford-Burnham Medical Research Institute |
Truncated car peptides and methods and compositions using truncated car peptides
|
RU2475247C2
(ru)
*
|
2011-03-05 |
2013-02-20 |
Республика Северная Осетия-Алания "Всероссийское общество изобретателей и рационализаторов" ("ВОИР") |
Способ профилактики несостоятельности кишечного анастомоза
|
CN102133190A
(zh)
*
|
2011-03-16 |
2011-07-27 |
中国药科大学 |
一种转铁蛋白纳米粒及其制备方法和用途
|
CO6540157A1
(es)
|
2011-04-15 |
2012-10-16 |
Univ Antioquia |
Proceso continuo para la elaboracion de nanoparticulas y nanoparticulas obtenidas mediante dicho proceso
|
BR112013027674A2
(pt)
|
2011-04-28 |
2016-09-06 |
Abraxis Bioscience Llc |
"usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
|
US10179801B2
(en)
|
2011-08-26 |
2019-01-15 |
Sanford-Burnham Medical Research Institute |
Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
|
SG11201401946QA
(en)
|
2011-11-01 |
2014-05-29 |
Celgene Corp |
Methods for treating cancers using oral formulations of cytidine analogs
|
WO2013085902A1
(en)
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
WO2013084207A1
(pt)
|
2011-12-07 |
2013-06-13 |
Universidade Do Minho |
Formulações micelares proteicas e respectivo método de produção
|
DK2790675T3
(da)
|
2011-12-14 |
2019-09-09 |
Abraxis Bioscience Llc |
Anvendelse af polymerexcipienser til frysetørring eller frysning af partikler
|
RU2499991C2
(ru)
*
|
2011-12-14 |
2013-11-27 |
Государственное бюджетное образовательное учреждение высшего профессионального образования "Северный государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации |
Способ дифференциальной диагностики типа гепаторенального синдрома алкогольного генеза
|
WO2013166408A1
(en)
|
2012-05-03 |
2013-11-07 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
EP2844295A1
(en)
|
2012-05-03 |
2015-03-11 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
US20140235631A1
(en)
|
2012-07-27 |
2014-08-21 |
Antonius Martinus Gustave Bunt |
Efflux inhibitor compositions and methods of treatment using the same
|
CA2890018A1
(en)
|
2012-11-05 |
2014-05-08 |
Nant Holdings Ip, Llc |
Substituted indol-5-ol derivatives and their therapeutical applications
|
CA2890002A1
(en)
|
2012-11-05 |
2014-05-08 |
Nant Holdings Ip, Llc |
Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
WO2014078435A1
(en)
*
|
2012-11-14 |
2014-05-22 |
W. R. Grace & Co.-Conn. |
Compositions containing a biologically active material and a non-ordered inorganic oxide
|
JP5999765B2
(ja)
*
|
2012-12-07 |
2016-09-28 |
バイオアバイラビリティ,インク. |
栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムq10調製物
|
PT106738B
(pt)
|
2013-01-09 |
2015-06-08 |
Hovione Farmaciencia Sa |
Método para o controlo do fenómeno de degradação difusional de ostwald (ostwald ripening) no processamento de partículas de um ingrediente farmacêutico
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
CN105120859B
(zh)
|
2013-02-11 |
2018-10-09 |
阿布拉科斯生物科学有限公司 |
治疗黑素瘤的方法
|
ITBN20130001A1
(it)
*
|
2013-02-19 |
2014-08-20 |
Prodal S C A R L |
Particelle biopolimeriche sub-micrometriche per la veicolazione di composti attivi in campo alimentare, farmaceutico e cosmetico e procedimento per la loro preparazioneparticelle biopolimeriche sub-micrometriche per la veicolazione di composti attivi
|
EP2968254B1
(en)
|
2013-03-12 |
2020-04-22 |
Abraxis BioScience, LLC |
Methods of treating lung cancer
|
AU2014228386B2
(en)
|
2013-03-13 |
2018-11-29 |
Abraxis Bioscience, Llc |
Methods of treatment of pediatric solid tumor
|
US9962373B2
(en)
|
2013-03-14 |
2018-05-08 |
Abraxis Bioscience, Llc |
Methods of treating bladder cancer
|
US9907910B2
(en)
|
2013-03-15 |
2018-03-06 |
Windgap Medical, Inc. |
Portable drug mixing and delivery device and associated methods
|
US9550760B2
(en)
|
2013-03-15 |
2017-01-24 |
Nantbioscience, Inc. |
Substituted indol-5-ol derivatives and their therapeutic applications
|
JP6560187B2
(ja)
|
2013-03-15 |
2019-08-14 |
ウインドギャップ メディカル インコーポレイテッド |
携帯型薬剤混合及び送達システム並びに方法
|
US10569017B2
(en)
|
2013-03-15 |
2020-02-25 |
Windgap Medical, Inc. |
Portable drug mixing and delivery device and associated methods
|
US20150367072A1
(en)
|
2013-03-15 |
2015-12-24 |
Windgap Medical, Llc |
Portable Drug Mixing and Delivery Device and Associated Methods
|
KR101329646B1
(ko)
|
2013-05-02 |
2013-11-14 |
주식회사 지니스 |
표적지향증폭형 항암나노입자 및 이의 제조방법
|
CN103393632B
(zh)
*
|
2013-07-26 |
2015-05-13 |
齐鲁制药(海南)有限公司 |
一种卡巴他赛药物组合物及其制备方法
|
CN104368007A
(zh)
*
|
2013-08-12 |
2015-02-25 |
于湛 |
可注射蛋白基花样结构载药微纳材料与内耳跨膜给药缓释制剂及其制备方法
|
KR20150047336A
(ko)
|
2013-10-24 |
2015-05-04 |
삼성전자주식회사 |
나노입자, 이를 제조하는 방법, 및 이의 용도
|
CN104758942A
(zh)
*
|
2014-01-02 |
2015-07-08 |
国家纳米科学中心 |
基于蛋白质的药理活性物质组合物及其制备方法和应用
|
CN103705469B
(zh)
*
|
2014-01-03 |
2016-01-20 |
中国医学科学院药用植物研究所 |
一种和厚朴酚纳米粒及其制备方法
|
WO2015123082A1
(en)
*
|
2014-02-14 |
2015-08-20 |
Boston Scientific Scimed, Inc. |
Rapidly degrading embolic particles with therapeutic agent release
|
CN103861115B
(zh)
*
|
2014-03-18 |
2017-04-19 |
常州市第一人民医院 |
一种血红蛋白纳米粒及其制备方法
|
US20150359810A1
(en)
|
2014-06-17 |
2015-12-17 |
Celgene Corporation |
Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine
|
CN104434808A
(zh)
|
2014-07-03 |
2015-03-25 |
石药集团中奇制药技术(石家庄)有限公司 |
一种治疗性纳米粒子及其制备方法
|
US11116903B2
(en)
|
2014-08-18 |
2021-09-14 |
Windgap Medical, Inc |
Compression seal for use with a liquid component storage vial of an auto-injector
|
WO2016088384A1
(ja)
*
|
2014-12-05 |
2016-06-09 |
国立大学法人神戸大学 |
in vivoステルス性ナノ粒子
|
CN105727303B
(zh)
*
|
2014-12-12 |
2019-06-28 |
四川科伦药物研究院有限公司 |
一种高载卡巴他赛药物的白蛋白组合物及其制剂和制备方法
|
CN104490797A
(zh)
*
|
2014-12-22 |
2015-04-08 |
深圳海王药业有限公司 |
一种多相稳定的白蛋白结合型卡巴他塞
|
AU2015383881B2
(en)
|
2015-02-27 |
2021-01-28 |
Nantbioscience, Inc. |
Pyrimidine derivatives as kinase inhibitors and their therapeutical applications
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
CN106137969B
(zh)
*
|
2015-04-03 |
2020-05-15 |
四川科伦药物研究院有限公司 |
多西他赛白蛋白纳米粒药物组合物及其制备方法及应用
|
AU2016266657B2
(en)
|
2015-04-15 |
2020-09-17 |
Windgap Medical, Llc |
Removable actuating cap for use with an auto-injector assembly
|
US10071141B2
(en)
|
2015-05-08 |
2018-09-11 |
Spectral Platforms, Inc. |
Albumin-based non-covalent complexes and methods of use thereof
|
US9763892B2
(en)
|
2015-06-01 |
2017-09-19 |
Autotelic Llc |
Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
|
EP3313447A2
(en)
|
2015-06-25 |
2018-05-02 |
Sanford Burnham Prebys Medical Discovery Institute |
Compositions for delivery to and treatment of atherosclerotic plaques
|
SG10202107198SA
(en)
|
2015-06-29 |
2021-08-30 |
Abraxis Bioscience Llc |
Methods of treating epithelioid cell tumors
|
CN105055341A
(zh)
*
|
2015-08-13 |
2015-11-18 |
黑龙江泰华源生物技术有限责任公司 |
一种紫杉醇白蛋白结合型冻干制剂及其制备方法
|
CA2994300C
(en)
|
2015-08-13 |
2023-12-05 |
Windgap Medical, Inc. |
Mixing and injection device with sterility features
|
CN105816885A
(zh)
*
|
2016-04-15 |
2016-08-03 |
北京大学 |
一种药物白蛋白纳米粒的制备及其应用方法
|
BE1023653B1
(nl)
*
|
2016-04-29 |
2017-06-07 |
Rousselot B.V. |
Eiwit gebaseerd excipient voor actieve farmaceutische stoffen
|
ES2925656T3
(es)
*
|
2016-04-29 |
2022-10-19 |
Rousselot B V |
Excipiente basado en proteínas para principios farmacéuticos activos
|
CN105944109B
(zh)
*
|
2016-05-03 |
2019-06-11 |
四川大学 |
一种肾小球靶向的蛋白纳米颗粒药物组合物及其用途
|
CN106310221B
(zh)
*
|
2016-08-25 |
2019-11-22 |
齐鲁制药有限公司 |
一种含有卡非佐米的药物组合物及其制备方法
|
RU2021128415A
(ru)
*
|
2016-09-06 |
2021-11-08 |
Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч |
Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения
|
CA3039195A1
(en)
*
|
2016-10-10 |
2018-04-19 |
Abraxis Bioscience, Llc |
Nanoparticle formulations and methods of making and using thereof
|
ES2918976T3
(es)
*
|
2016-11-30 |
2022-07-21 |
Dukebox Sp Z O O |
Un método para fabricar una solución de nanopartículas de ácido acetilsalicílico o diosmina o drotaverina
|
WO2018175346A1
(en)
|
2017-03-20 |
2018-09-27 |
Spectral Platforms, Inc. |
Spectroscopic methods to detect and characterize microorganisms
|
CN110753541A
(zh)
*
|
2017-04-24 |
2020-02-04 |
Zy治疗公司 |
用于体内递送的药物组合物、基本上不溶于水的药理学活性剂的制备方法
|
CN107412783B
(zh)
|
2017-04-28 |
2020-09-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
一种包裹有难溶于水药物的蛋白质颗粒的制备方法
|
EP3628047A1
(en)
|
2017-05-02 |
2020-04-01 |
Sanford Burnham Prebys Medical Discovery Institute |
Tumor associated monocyte/macrophage binding peptide and methods of use thereof
|
US10800760B2
(en)
|
2017-05-31 |
2020-10-13 |
Nantbio, Inc. |
Trk inhibition
|
US10738033B2
(en)
|
2017-05-31 |
2020-08-11 |
Nantbio, Inc. |
Trk inhibition
|
WO2019016692A1
(en)
*
|
2017-07-21 |
2019-01-24 |
Emcure Pharmaceuticals Limited |
PARTICLE SIZE STABILIZATION OF PROTEIN-RELATED PARTICLES AND RELATED METHODS
|
CN107412172A
(zh)
*
|
2017-08-04 |
2017-12-01 |
南京拉克森生物医药科技有限公司 |
一种紫杉醇白蛋白纳米混悬剂冻干粉及其制备工艺
|
EP3672618A4
(en)
*
|
2017-08-25 |
2021-07-07 |
Nal Pharmaceutical Group Limited |
COMPOSITIONS AND METHODS OF ADMINISTRATION OF PHARMACOLOGICAL AGENTS
|
IL274444B1
(en)
|
2017-11-06 |
2024-02-01 |
Rapt Therapeutics Inc |
Chemokine receptor modulators for the treatment of Epstein-Barr virus-positive cancer
|
WO2019183146A1
(en)
|
2018-03-20 |
2019-09-26 |
Abraxis Bioscience, Llc |
Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin
|
CN108524452A
(zh)
*
|
2018-05-08 |
2018-09-14 |
辽宁大学 |
一种紫杉醇白蛋白纳米粒的制备方法和应用
|
CN113905722A
(zh)
*
|
2019-01-22 |
2022-01-07 |
锐创生物医药(香港)有限公司 |
白蛋白纳米颗粒、其制备方法和用途
|
US20220119450A1
(en)
|
2019-02-04 |
2022-04-21 |
University Of Tartu |
Bi-specific extracellular matrix binding peptides and methods of use thereof
|
US20220218789A1
(en)
|
2019-05-10 |
2022-07-14 |
Nant Holdings Ip, Llc |
Nogapendekin Alfa-Inbakicept For Immune Stimulant Therapies And Treatment Of Viral Infections
|
CA3158764A1
(en)
|
2019-10-28 |
2021-05-06 |
Abraxis Bioscience, Llc |
Pharmaceutical compositions of albumin and rapamycin
|
US11318189B1
(en)
|
2020-05-13 |
2022-05-03 |
Nantcell, Inc. |
IL-15 agonist drug combinations for immune therapy
|
CN114681408B
(zh)
*
|
2020-12-26 |
2023-06-23 |
四川汇宇制药股份有限公司 |
白蛋白结合型紫杉醇纳米粒的制备方法
|
EP4036580A1
(en)
*
|
2021-02-01 |
2022-08-03 |
Oxford University Innovation Limited |
Drug loaded cavitation agent
|
EP4035655A1
(en)
*
|
2021-02-01 |
2022-08-03 |
Oxford University Innovation Limited |
Immune modulating particles
|
WO2024081674A1
(en)
|
2022-10-11 |
2024-04-18 |
Aadi Bioscience, Inc. |
Combination therapies for the treatment of cancer
|